Rate control in patients with pacemaker affected by brady-tachy form of sick sinus syndrome

American Heart Journal

Volumn 154, Issue 1, 2007, Pages 193-200

  Boriani, Giuseppe ^a   Padeletti, Luigi ^b   Santini, Massimo ^c   Gulizia, Michele ^d   Orazi, Serafino ^e   Botto, GianLuca ^f   Capucci, Alessandro ^g   Biffi, Mauro ^a   Martignani, Cristian ^a   Ricci, Renato ^c   Vimercati, Marco ^h   DiStefano, Paola ^h   Grammatico, Andrea ^h  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c SAN FILIPPO NERI HOSPITAL   (Italy)

^d Garibaldi Nesima Hospital   (Italy)

^e SAN CAMILLO DE LELLIS HOSPITAL   (Italy)

^f SANT ANNA HOSPITAL   (Italy)

^g GUGLIELMO DA SALICETO HOSPITAL   (Italy)

^h Clinical Department   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DILTIAZEM; METOPROLOL; SOTALOL; VERAPAMIL;

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; BRADYCARDIA; FEMALE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SICK SINUS SYNDROME; SUPRAVENTRICULAR TACHYCARDIA; TACHYCARDIA; THROMBOEMBOLISM;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANTI-ARRHYTHMIA AGENTS; CARDIAC PACING, ARTIFICIAL; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART RATE; HUMANS; MALE; PACEMAKER, ARTIFICIAL; SICK SINUS SYNDROME; SURVIVAL RATE;

EID: 34250361438     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.04.001     Document Type: Article

References (20)

1. Fuster V., Ryden L.E., Cannom D.S., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary. Eur J Heart 27 (2006) 1979-2030
2. Montanez A., Hennekens C.H., Zebede J., et al. Pacemaker mode selection: the evidence from randomized trials. Pacing Clin Electrophysiol 26 (2003) 1270-1282
3. The AFFIRM investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347 (2002) 1834-1850
4. Ahmad K., and Dorian P. Rate control in atrial fibrillation: looking beyond the average heart rate. Curr Opin Cardiol 21 (2006) 88-93
5. Israel C.W., Hugl B., Unterberg C., et al. Pace-termination and pacing for prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapy. J Cardiovasc Electrophysiol 12 (2001) 1121-1128
6. Swerdlow C.D., Schsls W., Dijkman B., et al. Detection of atrial fibrillation and flutter by a dual chamber implantable cardioverter-defibrillator. Circulation 101 (2000) 878-885
7. Hagens V.E., Ranchor A.V., Van Sonderen E., et al. Effect of rate or rhythm control on quality of life in persistent atrial fibrillation: results from the Rate Control Versus Electrical Cardioversion (RACE) Study. J Am Coll Cardiol 43 (2004) 241-247
8. Ricci R., Santini M., Padeletti L., et al. Atrial tachyarrhythmia recurrence temporal patterns in bradycardia patients implanted with antitachycardia pacemakers. J Cardiovasc Electrophysiol 15 (2004) 44-51
9. Boriani G., Padeletti L., Santini M., et al. Predictors of atrial antitachycardia pacing efficacy in patients affected by brady-tachy form of sick sinus syndrome and implanted with a DDDRP device. J Cardiovasc Electrophysiol 16 (2005) 1-10
10. Healey J.S., Toff W.D., Lamas G.A., et al. Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data. Circulation 114 (2006) 11-17
11. Boriani G., Diemberger I., Biffi M., et al. How, why and when may atrial defibrillation find a specific role in implantable devices? A clinical viewpoint. Pacing Clin Electrophysiol 30 (2007) 422-433
12. Ozcan C., Jahangir A., Friedman P.A., et al. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N Engl J Med 344 (2001) 1043-1051
13. Sweeney M.O., Hellkamp A.S., Ellenbogen K.A., et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 107 (2003) 2932-2937
14. Van Gelder I.C., Wyse D.G., Chandler M.L., et al. Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies. Europace 8 (2006) 935-942
15. Cooper H.A., Bloomfield D.A., Bush D.E., et al. Relation between achieved heart rate and outcomes in patients with atrial fibrillation (from the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] Study). Am J Cardiol 93 (2004) 1247-1253
16. Israel C.W., Gronefeld G., Ehrlich J.R., et al. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device. Implications for optimal patient care. J Am Coll Cardiol 43 (2004) 47-52
17. Capucci A., Santini M., Padeletti L., et al. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol 46 (2005) 1913-1920
18. Boriani G., Biffi M., Diemberger I., et al. Rate control in atrial fibrillation: choice of treatment and assessment of efficacy. Drugs 63 (2003) 1489-1509
19. Roth A., Harrison E., Mitani G., et al. Efficacy and safety of medium- and high dose diltiazem alone and in combination with digoxin for control of heart rate at rest and during exercise in patients with chronic atrial fibrillation. Circulation 73 (1986) 316-324
20. Van Gelder I.C., Van Veldhuisen D.J., Crijns H.J., et al. RAte Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure. Background, aims, and design of RACE. Am Heart J 152 (2006) 420-426